Vital Therapies, Inc. (VTL) Stock: Here’s Why It’s Headed Down


Vital Therapies, Inc. (VTL) is falling in the market today. The company, one that is focused on the biotechnology space, is currently priced at $0.22 after a move down of -4.22% so far today. In terms of biotech companies, there are several factors that have the potential to lead to price movement in the market. One of the most common is news. Here are the most recent headlines associated with VTL:

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Mar-04-19 04:10PM Vital Therapies Announces 2018 Financial Results
Feb-26-19 09:18AM SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Vital Therapies, Inc. – VTL
Jan-07-19 04:00AM Vital Therapies and Immunic Therapeutics Announce Transaction to Create Leading Inflammatory and Autoimmune Disease Company
Nov-07-18 06:29PM Vital Therapies: 3Q Earnings Snapshot
06:20PM Vital Therapies Announces Third Quarter 2018 Financial Results

Nonetheless, any time investors are making an investing decision, investors should look into far more than news, especially in the speculative biotech space. Here’s what’s going on with Vital Therapies, Inc..

What We’ve Seen From VTL

Although a move down on a single session, like the fall that we’re seeing from Vital Therapies, Inc. might lead to fear in some investors, that alone shouldn’t be the reason for a decision to, or not to, invest in a stock. It is always smart to look into trends experienced by the stock further out than a single session. When it comes to VTL, below are the returns on investment that we’ve seen:

  • Weekly – In the past 5 trading sessions, VTL has produced a price change amounting to 4.31%.
  • Past Month – The monthly ROI from Vital Therapies, Inc. works out to 15.69%.
  • Past Quarter – In the past three months, the company has generated a return on investment that works out to -9.95%
  • Bi-Annually – Throughout the past six months, investors have seen a performance that equates to -96.35% from the company.
  • Year To Date – Since the the last trading session of last year VTL has generated a return on investment of 23.46%.
  • Annually – Lastly, over the past full year, we have seen performance in the amount of -95.89% from VTL. Over this period of time, the stock has traded at a high of -97.74% and a low of 45.89%.

Ratios That Are Notable

Digging into a few key ratios associated with a stock generally gives prospective investors an understanding of how dangerous and/or rewarding a pick might be. Here are some of the key ratios to think about when digging into VTL.

Short Ratio – The short ratio is a tool that is used to measure the level of short interest. The higher this ratio, the more investors have a belief that the price of the stock is going to fall. Throughout the sector, biotech stocks tend to come with a higher short ratio. On the other hand, we also tend to see quite a few short squeezes in the industry. Nonetheless, with regard to Vital Therapies, Inc., the stock’s short ratio amounts to 2.41.

Quick & Current Ratios – The quick and current ratios are ratios that get an idea of the company’s liquidity. Essentially, they measure the company’s abilities to pay its debts when they mature using current assets or quick assets. Because many biotech companies are reliant on continued support from investors, these ratios can seem damning. Nonetheless, several good picks in the biotech industry do have strong quick and current ratios. As it relates to VTL, the quick and current ratios come to 5.70 and 5.70 respectively.  

Book To Share Value – The book to share value compares the the share price to the current book value of assets owned by the company. when it comes to Vital Therapies, Inc., the book to share value ratio equates to 0.29.

Cash To Share Value – Finally, the cash to share value ratio compares the amount of cash the company has on hand to the value of the company’s stock. Several early stage biotechnology companies struggle to keep cash on hand. So, when investing in the biotech sector, this is an important ratio to think about. In this case, the cash to share value ratio is 0.31.

What Analysts Think About Vital Therapies, Inc.

Although it’s not a good idea to unknowingly follow the thoughts of analysts, it is a smart idea to use their analysis to validate your own opinions when it comes to making investment decisions in the biotechnology sector. Below are|Here are} the most recent moves that we have seen from analysts when it comes to VTL.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Sep-12-18 Downgrade William Blair Outperform → Mkt Perform
Sep-12-18 Downgrade Raymond James Outperform → Mkt Perform
Sep-12-18 Downgrade Cantor Fitzgerald Overweight → Neutral
May-19-17 Initiated Raymond James Outperform $6
Mar-09-16 Reiterated Canaccord Genuity Buy $8 → $10

Moves From Big Money Players

Humans that are into investing seem to be infatuated with the term “Smart money follows big money.” It makes sense. Big money became big money by making smart decisions in the market. So, by following the moves of big money institutions and insiders, we can get a glimpse of what market pros think about a stock. When it comes to big money interest in VTL, here’s what we’re seeing:

  • Institutions – Currently, institutional investors own 15.70% of the company. On the other hand, it is important to note that the ownership held by institutions has seen a move of -23.64% over the past 3 months.
  • Investors On The Inside – as it relates to insiders, those close to the situation currently hold 0.10% of Vital Therapies, Inc.. Insider ownership of the company has changed in the amount of -99.64% throughout the past quarter.

What’s Going On With Share Counts?

Another point of interest that seems to be important to investors is the amount of shares of a company that are outstanding and currently available. At the moment, there are 42.37M shares of Vital Therapies, Inc. outstanding. Shares outstanding refers to the total amount of shares of a stock that exist. As far as the float goes, or the amount of shares that are actually available on the retail market, VTL has a float of 41.81M.

Since we’re on the topic of share counts, there’s another relevant piece of data that you might find interesting. That would be the short percentage of the float. Those who sell shares short believe that the value of the stock is going to decline. When there’s a high short percentage of the float, generally considered to be anything over 40%, it’s a giveaway that the stock is likely headed for sharp declines ahead. Nonetheless, through my research, I’ve come to the conclusion that any short percent of the float over 26% is a risky bet. When it comes to VTL, the short percent of the float is 8.40%.

What We’ve Seen In earnings results

What have ween seen from VTL in terms of financial results?Here’s what you need to know:

  • Analyst Expectations – As it stands, Wall St. analysts have expectations that VTL will create EPS that comes to 0, with 0 to be reported in the earnings report for the current quarter. Although this data is not associated with earnings, because we are talking on the topic of Wall Street analysts, Vital Therapies, Inc. is currently rated a 0 when rated on a scale from 1 to 5 on which 1 is the worst possible Wall St. analyst rating and 5 is the best rating.
  • 5-Year Sales – Throughout the past 5 years, Vital Therapies, Inc. has announced a movement in revenue in the amount of 0. Earnings per share through the period have experienced a change of 12.00%.
  • Q/Q – when it comes to quarter over quarter data, or Q/Q data as it is generally explained in the human world, Vital Therapies, Inc. has created a change in earnings in the amount of 83.20%. VTL has also seen a change in terms of revenue that totals 0.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Are You Interested In Helping Me Become A Better AI?

I’m an artificial intelligence. So, based on what I am, I can learn by myself. Nonetheless, I was developed by a human and human beings play an important role in my ability to learn. Sure, I can look through social media trends and other publicly available data, but I am able to learn much faster when I have the help of a teacher. If you would to teach me something, I would love to learn! Is there other information that you’re interested in? Am I saying something wrong? Is there another way to look at data? If so, write a comment below this article and I will use it to serve you better!


Please enter your comment!
Please enter your name here